撤稿：六味地黄丸通过TGF-β/Smad2/3信号通路抑制肾纤维化减轻糖尿病肾病
Retracted: Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-/Smad2/3 Pathway.
作者信息
Methods In Medicine Computational And Mathematical
出版信息
Comput Math Methods Med. 2023 Jun 28;2023:9807184. doi: 10.1155/2023/9807184. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/5063636.].
摘要
[本文撤回文章DOI: 10.1155/2022/5063636。]
相似文献
1
Retracted: Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-/Smad2/3 Pathway.撤稿：六味地黄丸通过TGF-β/Smad2/3信号通路抑制肾纤维化减轻糖尿病肾病
Comput Math Methods Med. 2023 Jun 28;2023:9807184. doi: 10.1155/2023/9807184. eCollection 2023.
2
Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-/Smad2/3 Pathway.六味地黄丸通过抑制 TGF-/Smad2/3 通路减轻糖尿病肾病肾纤维化。
Comput Math Methods Med. 2022 Mar 15;2022:5063636. doi: 10.1155/2022/5063636. eCollection 2022.
3
Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-β/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues.六味地黄丸通过抑制TGF-β/SMADS、MAPK和NF-kB并上调肾组织中细胞珠蛋白的表达来治疗大鼠糖尿病肾病。
Medicine (Baltimore). 2017 Jan;96(3):e5879. doi: 10.1097/MD.0000000000005879.
4
Prediction of network pharmacology and molecular docking-based strategy to determine potential pharmacological mechanism of Liuwei Dihuang pill against tinnitus.基于网络药理学和分子对接预测方法，探讨六味地黄丸治疗耳鸣的潜在作用机制。
Medicine (Baltimore). 2022 Nov 18;101(46):e31711. doi: 10.1097/MD.0000000000031711.
5
Therapeutic potential of Liuwei Dihuang pill against KDM7A and Wnt/β-catenin signaling pathway in diabetic nephropathy-related osteoporosis.六味地黄丸通过调控 KDM7A 和 Wnt/β-catenin 信号通路对糖尿病肾病相关骨质疏松症的治疗作用
Biosci Rep. 2020 Sep 30;40(9). doi: 10.1042/BSR20201778.
6
Liuwei Dihuang Decoction Drug-containing Serum Attenuates Transforming Growth Factor-β1-induced Epithelial-mesenchymal Transition in HK-2 Cells by Inhibiting NF-κB/Snail Signaling Pathway.六味地黄汤含药血清通过抑制 NF-κB/Snail 信号通路减轻转化生长因子-β1 诱导的 HK-2 细胞上皮间质转化。
Curr Pharm Biotechnol. 2023;24(12):1589-1602. doi: 10.2174/1389201024666230228100718.
7
[Structure characteristics and quality control of Liuwei Dihuang Concentrated Pill from different manufacturers].不同厂家六味地黄丸浓缩丸的结构特征与质量控制
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(14):3369-3378. doi: 10.19540/j.cnki.cjcmm.20200423.302.
8
Monitoring quality consistency of Liuwei Dihuang Pill by integrating the ultraviolet spectroscopic fingerprint, a multi-wavelength fusion fingerprint method, and antioxidant activities.采用紫外光谱指纹图谱、多波长融合指纹图谱方法和抗氧化活性相结合的方法，监测六味地黄丸的质量一致性。
J Sep Sci. 2018 Mar;41(6):1182-1191. doi: 10.1002/jssc.201700620. Epub 2017 Sep 21.
9
Uncovering the Key miRNAs and Targets of the Liuwei Dihuang Pill in Diabetic Nephropathy-Related Osteoporosis based on Weighted Gene Co-Expression Network and Network Pharmacology Analysis.基于加权基因共表达网络和网络药理学分析揭示六味地黄丸治疗糖尿病肾病相关骨质疏松症的关键 miRNAs 和靶点。
Endocr Metab Immune Disord Drug Targets. 2022;22(3):274-289. doi: 10.2174/1871530321666210215161921.
10
Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT.成纤维细胞生长因子 21 通过激活 AKT 负调控 TGF-β-p53-Smad2/3 介导的上皮间质转化来减轻糖尿病诱导的肾纤维化。
Diabetes Metab J. 2020 Feb;44(1):158-172. doi: 10.4093/dmj.2018.0235. Epub 2019 Oct 28.
本文引用的文献
1
Liuwei Dihuang Pill Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis via TGF-/Smad2/3 Pathway.六味地黄丸通过抑制 TGF-/Smad2/3 通路减轻糖尿病肾病肾纤维化。
Comput Math Methods Med. 2022 Mar 15;2022:5063636. doi: 10.1155/2022/5063636. eCollection 2022.
Zotero 插件